Stock Events

Stock Events

Avalo Therapeutics (AVTX) Q3 2023 Earnings

9NovConfirmed

Nov 22

Q4 2022

Q2 2023

Q3 2023

-1.1

-0.62

-0.14

0.34

Details

Expected EPS

-1.1

Actual EPS

-0.11

Surprise EPS

0.99

Surprise Percent

+90%

Description

Avalo Therapeutics (AVTX) has reported earnings of -0.11 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.